Germany suspends some drug approvals on concern over Indian data

December 5, 2014 7:24 PM

13 0

FRANKFURT/LONDON (Reuters) - A German drugs regulator is suspending the marketing approval of some generic drugs due to concerns over the quality of data from clinical trials conducted by India's GVK Biosciences.

The quality of Indian pharmaceuticals has come under fire this year, with regulators in Europe and the United States citing problems ranging from data manipulation to sanitation and banning the import of certain products from several firms.

Read more

To category page